Efficacy and safety of Guben Tongluo formula in treating chronic kidney disease (stage G3): a multicenter randomized controlled clinical trial
LP + GTF group demonstrated a better clinical efficacy rate than LP group. GTF regulates serum lipid levels and has anti-inflammatory, antioxidative, and anti-renal fibrosis effects. GTF showed potential benefits in this small multicenter randomized controlled trial, warranting confirmation in larger, fully blinded randomized trials.
Authors
- Lianxiang Duan
- Xuezhong Gong (ORCID: https://orcid.org/0000-0002-4496-7972)
- Yanbo Fan (ORCID: https://orcid.org/0000-0002-3845-7562)
- Jie Chen (ORCID: https://orcid.org/0000-0002-7712-5982)
- Ling Chen (ORCID: https://orcid.org/0000-0002-0293-5841)
- Yue Guo
- Ziyang Liu (ORCID: https://orcid.org/0000-0002-3067-9523)
- Yiqing Yang (ORCID: https://orcid.org/0000-0001-6090-1378)
- Jing Hu (ORCID: https://orcid.org/0009-0007-8446-0862)
Institutions
- Shanghai University of Traditional Chinese Medicine (CN)
- Seventh People's Hospital of Shanghai (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-10-24
- DOI
- https://doi.org/10.3389/fmed.2025.1691637
- Primary Topic
- Metabolism and Genetic Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Shanghai Municipal Health Commission